Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 5.4B | 5.1B | 5.2B | 5.4B |
Cost of revenue | 3.1B | 3.0B | 3.2B | 3.1B |
Gross profit | 2.3B | 2.1B | 1.9B | 2.3B |
Operating expense | ||||
Research & development | 246.9M | 244.4M | 241.8M | 230.6M |
Selling general and admin | 1.1B | 810.2M | 770.8M | 910.6M |
Other operating expenses | — | — | — | — |
Operating income | 980.0M | 1.1B | 930.3M | 1.1B |
Non operating interest income | ||||
Income | 42.9M | 67.7M | 78.9M | 91.7M |
Expense | 203.2M | 218.6M | 216.1M | 236.6M |
Other income expense | -28.3M | 270.1M | -142.3M | 492.1M |
Pretax income | 791.4M | 1.2B | 650.8M | 1.5B |
Tax provision | 210.1M | 227.2M | 28.3M | 298.4M |
Net income | 621.6M | 962.0M | 624.2M | 1.2B |
Basic EPS | 1.4 | 2.1 | 1.3 | 2.5 |
Diluted EPS | 1.3 | 2.0 | 1.3 | 2.5 |
Basic average shares | 460.8M | 466.3M | 466.1M | 472.1M |
Diluted average shares | 463.5M | 469.6M | 468.4M | 473.9M |
EBITDA | 1.3B | 1.4B | 1.3B | 1.5B |
Net income from continuing op. | 621.6M | 962.0M | 624.2M | 1.2B |
Minority interests | -1.7M | -5.1M | 0 | -3.4M |
Preferred stock dividends | — | — | — | — |